Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,279,000 | 940,000 | 580,000 | 284,000 | 785,000 |
| Depreciation Amortization | 370,000 | 276,000 | 181,000 | 88,000 | 353,000 |
| Income taxes - deferred | -110,000 | -67,000 | -54,000 | -21,000 | -74,000 |
| Accounts receivable | -128,000 | -74,000 | -117,000 | -103,000 | -363,000 |
| Other Working Capital | 130,000 | -20,000 | -240,000 | -33,000 | -237,000 |
| Other Operating Activity | 822,000 | 594,000 | 472,000 | 170,000 | 731,000 |
| Operating Cash Flow | $2,363,000 | $1,649,000 | $822,000 | $385,000 | $1,195,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,400,000 | -1,107,000 | -730,000 | -144,000 | -650,000 |
| Purchase Of Investment | -1,000,000 | -694,000 | -313,000 | -72,000 | -890,000 |
| Sale Of Investment | 722,000 | 575,000 | 399,000 | 162,000 | 1,149,000 |
| Purchase Sale Intangibles | -45,000 | N/A | N/A | N/A | -64,000 |
| Other Investing Activity | -98,000 | -78,000 | -35,000 | -8,000 | -59,000 |
| Investing Cash Flow | $-1,776,000 | $-1,304,000 | $-679,000 | $-62,000 | $-450,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,988,000 | 1,988,000 | N/A | N/A | N/A |
| Debt Repayment | -425,000 | -425,000 | N/A | N/A | N/A |
| Common Stock Issued | 821,000 | 634,000 | 465,000 | 106,000 | 505,000 |
| Common Stock Repurchased | -2,016,000 | -1,090,000 | -161,000 | -156,000 | -1,352,000 |
| Financing Cash Flow | $368,000 | $1,107,000 | $304,000 | $-50,000 | $-847,000 |
| Beginning Cash Position | 270,000 | 270,000 | 270,000 | 270,000 | 372,000 |
| End Cash Position | 1,225,000 | 1,722,000 | 717,000 | 543,000 | 270,000 |
| Net Cash Flow | $955,000 | $1,452,000 | $447,000 | $273,000 | $-102,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,363,000 | 1,649,000 | 822,000 | 385,000 | 1,195,000 |
| Capital Expenditure | -1,400,000 | -1,107,000 | -730,000 | -144,000 | -650,000 |
| Free Cash Flow | 963,000 | 542,000 | 92,000 | 241,000 | 545,000 |